NCT01119911

Brief Summary

We hypothesize that peripheral venous catheter used for fluid administration can replace venipuncture blood sampling for selected basic analytes and thus reduce pain in infants under 2 years of age.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started May 2010

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2010

Completed
3 days until next milestone

First Submitted

Initial submission to the registry

May 4, 2010

Completed
6 days until next milestone

First Posted

Study publicly available on registry

May 10, 2010

Completed
2.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2012

Completed
Last Updated

March 19, 2012

Status Verified

March 1, 2012

First QC Date

May 4, 2010

Last Update Submit

March 16, 2012

Conditions

Keywords

Blood samplingVenipuncturePeripheral venous catheterComplete blood countBasic chemistryHemolysisPeripheral venous catheter replaces venipuncture.Peripheral venous catheter blood sampling reduces pain.

Outcome Measures

Primary Outcomes (1)

  • To evaluate the interchangeability of peripheral venous catheter and venipuncture for complete blood count and basic chemistry indices.

    Comparisons of complete blood count (including white and red blood cells, hemoglobin, hematocrit, mean corpuscular volume and hemoglobin, red cell distribution width, platelets, mean platelet volume) and basic chemistry indices (including sodium, potassium, glucose, chloride, urea) will be performed and hemolysis will be documented.

    Primary assessment will be done after data analysis of the first 20 participants, estimated to take up to 3 months.

Secondary Outcomes (1)

  • Assessment of infant's mood during procedures.

    Primary assessment will be done after data analysis of the first 20 participants, estimated to take up to 3 months.

Interventions

Venipuncture is performed on the opposite limb of the peripheral venous catheter. Within 3 minutes, a second sample is taken from existing peripheral venous catheter used for fluid administration. Intravenous fluids are then stopped for 30 seconds and a tourniquet applied proximal to the device for another 30 seconds. A 2-mL syringe is attached and 0.5 mL of blood aspirated and discarded. Thereafter, 2 mL blood is slowly drawn during about 15 seconds, into a different 2-mL syringe, to allow a gentle pumping action that may reduce vacuum in the syringe and thus hemolysis rates. Afterwards, the intravenous device is flushed with 2 mL normal saline and infusion restarted.

Eligibility Criteria

Age1 Week - 24 Months
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodProbability Sample
Study Population

All infants under 2 years of age, admitted to the Departments of Pediatrics and Pediatric Surgery, Meir Medical Center, who have a functioning peripheral venous catheter and require repeated blood sampling for diagnostic purposes.

You may qualify if:

  • Infants under 2 years of age.
  • Only hemodynamically stable infants.
  • Infants with peripheral venous catheter present for less than 72 hours.
  • At least 20 mL of fluids have been infused intravenously at the time of blood sampling.

You may not qualify if:

  • Infants with signs of catheter-related thrombophlebitis.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Meir Medical Center

Kfar Saba, 44281, Israel

RECRUITING

MeSH Terms

Conditions

PainHemolysis

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsPathologic Processes

Study Officials

  • Sivan Berger-Achituv, MD

    Meir Medical Center

    PRINCIPAL INVESTIGATOR
  • Ilan Erez, Dr

    Meir Medical Center

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 4, 2010

First Posted

May 10, 2010

Study Start

May 1, 2010

Study Completion

June 1, 2012

Last Updated

March 19, 2012

Record last verified: 2012-03

Locations